Longer Paxlovid treatment shows no benefit for long-COVID symptoms, study suggests Center for Infectious Disease Research and Policy 22:32 Tue, 01 Sep
DistroKid’s $2 billion valuation based on it being a pipeline for AI slop and copyright infringement, says Universal Complete Music Update 5d Copyright Law Law DistroKid All sources
USPTO pivot on PTAB oversight raises questions about PTAB control IPWatchdog.com 5d PTAB USPTO Patent Law All sources
Tesla and SpaceX take “Terafab” Trademark fight to Federal Court Teslarati 4d Trademark Law Tesla, Inc. SpaceX All sources
Cyril Vetter formally opposes the major labels’ ‘Off base’ Supreme Court Appeal amid high-stakes copyright recapture showdown Digital Music News 4d Copyright Law SCOTUS All sources
Kls martin set to deliver 500th lithoz-printed bioceramic implant by end of 3Q 2026 3D Printing Industry 2d Technology (UK) 3D Printing
EMA backs 12 new medicines, alongside key label expansions EU Reporter 2d European Medicines Agency Novo Nordisk
Hundreds of drugs and devices approved by the FDA are missing key safety studies, analysis finds San Francisco Chronicle 2d FDA California
Is this biotech stock too cheap to ignore after its latest pullback? The Motley Fool 3d Stock Markets (World) Stock Market Biotechnology
Cheap drugs, fake labels, non-functional QR codes: Karnataka FDA cancels 16 licences of retailers, wholesalers The Times of India 16h FDA India Pharma All sources
Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3% The Hindu Business Line 17:09 Wed, 09 Sep Novartis India Pharma All sources
Pfizer says its biggest headwinds are finally easing. Does that change the story for this ultra-high-yield dividend stock? The Motley Fool 11h Pharma
Move aside, Pfizer: This stock is the smarter Dividend buy right now The Motley Fool 18:13 Tue, 08 Sep AbbVie Pharma
